# Seismic Therapeutic

**Canonical:** https://apis.io/providers/seismic-therapeutic/  
**Website:** https://seismictx.com/  
**APIs profiled:** 0

Seismic Therapeutic is a clinical-stage biopharmaceutical company developing transformative biologic medicines for autoimmune and inflammatory diseases. The company pairs structural biology with machine learning through its proprietary IMPACT platform to design multi-functional antibodies and Immunoglobulin Sculpting (IgSc) enzymes across cell-mediated, allergic, and antibody-mediated immune diseases. Surfaced as a portfolio company of Bessemer Venture Partners, GV, and Lightspeed Venture Partners, it was added to the API Evangelist network as a lead for enrichment. As a therapeutics R&D company it publishes no public developer or API surface at seismictx.com; this profile captures its corporate identity only.

## Kin Score — 8.5 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 8.5).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotech, Biopharmaceutical, Immunology, Drug Discovery, Machine-Learning, Autoimmune, Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/seismic-therapeutic/). Scores are computed from the provider's own public artifacts under a published rubric.